Kalypto Medical

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Kalypto Medical - overview

Established

2006

Location

St. Petersburg, FL, US

Primary Industry

Medical Devices & Equipment

About

Kalypto Medical is dedicated to advancing healthcare by offering specialized medical services in Ear, Nose, and Throat (ENT) disorders, cardiology, and hand surgery, utilizing advanced techniques and a skilled team to deliver effective treatments. Founded in 2006 in St. Petersburg, US, Kalypto Medical focuses on healthcare services for ENT, cardiology, and hand surgery. In May 2012, the company was acquired by Smith & Nephew plc for an undisclosed amount.


Kalypto Medical has completed a total of four deals since inception. Kalypto Medical specializes in providing a comprehensive range of healthcare services focused on Ear, Nose, and Throat (ENT) disorders, cardiology, and hand surgery. Their core offerings encompass the diagnosis and treatment of various ENT infections such as sinusitis and tonsillitis, along with specialized care for hearing loss and swimmer's ear. The company employs a team of experienced specialists who utilize advanced medical techniques and technology to deliver effective treatments to their patients.


Kalypto Medical serves a diverse clientele, including individuals suffering from chronic ENT conditions, heart disease patients seeking cardiological care, and those requiring surgical intervention for hand-related issues. Their services are available to residents across multiple geographical markets, including Singapore and potentially extending to neighboring regions where healthcare access is vital. Kalypto Medical generates revenue through a structured fee-for-service model that typically involves direct transactions with patients seeking medical consultations and treatments. The company offers various services, with pricing tailored to individual procedures, such as consultations, diagnostic tests, and surgical interventions.


Patients may pay directly for services rendered, or their insurance providers may cover a portion of the costs, depending on the specific insurance plans available. The revenue structure is predominantly based on B2C transactions, where patients or their families engage with the clinic for healthcare services. The focus on specialized treatments, including those for ENT disorders and cardiology, positions Kalypto Medical as a key provider in the healthcare market, ensuring a steady flow of clients seeking expert medical care. Kalypto Medical is focused on launching new healthcare products, although specific release dates have not been disclosed.


The company is strategizing to expand its services into new markets, including potentially into neighboring regions of Singapore, although specific timelines for this expansion have not been provided. Recent funding will support these growth initiatives as the company looks to enhance its capabilities and reach.


Current Investors

Sequel Venture Partners, Sutter Hill Ventures

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Supplies, Therapeutic Devices

Website

www.kalyptomedical.com

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.